Drugs / Vincrisitne
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02393859 Comparator | Nov 2015 → Jul 2019 | acute lymphoblastic leukemia | Amgen | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vincrisitne | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02393859 ↗ |
| Route | Intravenous | “1.5 mg/m\^2/day IV” NCT02393859 ↗ |